UK markets closed

RAPT Therapeutics, Inc. (RAPT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
4.0100-0.0400 (-0.99%)
At close: 04:00PM EDT
4.0900 +0.08 (+2.00%)
After hours: 05:11PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
47,478
38,946
24,027
24,918
-
Other short-term investments
111,384
210,122
165,627
86,592
-
Total cash
158,862
249,068
189,654
111,510
-
Other current assets
2,920
3,626
3,319
4,088
-
Total current assets
161,782
252,694
192,973
115,598
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
17,043
17,728
10,425
10,064
-
Accumulated depreciation
-9,367
-8,249
-7,684
-7,082
-
Net property, plant and equipment
7,676
9,479
2,741
2,982
-
Other long-term assets
3,871
4,036
2,922
389
-
Total non-current assets
11,547
13,515
5,663
3,371
-
Total assets
173,329
266,209
198,636
118,969
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
5,176
3,365
1,999
2,383
-
Accrued liabilities
7,800
4,038
2,674
1,968
-
Deferred revenues
-
0
1,016
4,096
4,000
Other current liabilities
109
32
254
328
-
Total current liabilities
21,836
14,224
9,595
11,742
-
Non-current liabilities
Deferred revenues
-
0
511
863
0
Total non-current liabilities
4,458
6,819
2,661
3,048
-
Total liabilities
26,294
21,043
12,256
14,790
-
Stockholders' equity
Common stock
3
3
3
2
-
Retained earnings
-484,682
-367,884
-284,046
-214,842
-
Accumulated other comprehensive income
103
-26
-206
-177
-
Total stockholders' equity
147,035
245,166
186,380
104,179
-
Total liabilities and stockholders' equity
173,329
266,209
198,636
118,969
-